Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the …
Neurodegenerative diseases pose a substantial socioeconomic burden on society.
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …
Autophagy and ALS: mechanistic insights and therapeutic implications
Mechanisms of protein homeostasis are crucial for overseeing the clearance of misfolded
and toxic proteins over the lifetime of an organism, thereby ensuring the health of neurons …
and toxic proteins over the lifetime of an organism, thereby ensuring the health of neurons …
C9orf72 is required for proper macrophage and microglial function in mice
JG O'rourke, L Bogdanik, A Yáñez, D Lall, AJ Wolf… - Science, 2016 - science.org
Expansions of a hexanucleotide repeat (GGGGCC) in the noncoding region of the C9orf72
gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and …
gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and …
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Access provided by Oregon Health & Science …
New England Journal of Medicine homepage Access provided by Oregon Health & Science …
RNA-binding proteins with prion-like domains in health and disease
AF Harrison, J Shorter - Biochemical Journal, 2017 - portlandpress.com
Approximately 70 human RNA-binding proteins (RBPs) contain a prion-like domain (PrLD).
PrLDs are low-complexity domains that possess a similar amino acid composition to prion …
PrLDs are low-complexity domains that possess a similar amino acid composition to prion …
Pharmacotherapy for amyotrophic lateral sclerosis: a review of approved and upcoming agents
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder
involving loss of upper and lower motor neurons, with most cases ending in death within 3–5 …
involving loss of upper and lower motor neurons, with most cases ending in death within 3–5 …
An Overview of in vitro Methods to Study Microglia
R Timmerman, SM Burm, JJ Bajramovic - Frontiers in cellular …, 2018 - frontiersin.org
Neuroinflammation is a common feature in neurodegenerative diseases and strategies to
modulate neuroinflammatory processes are increasingly considered as therapeutic options …
modulate neuroinflammatory processes are increasingly considered as therapeutic options …
Vascular endothelial growth factor: a neurovascular target in neurological diseases
C Lange, E Storkebaum, CR De Almodóvar… - Nature Reviews …, 2016 - nature.com
Brain function critically relies on blood vessels to supply oxygen and nutrients, to establish a
barrier for neurotoxic substances, and to clear waste products. The archetypal vascular …
barrier for neurotoxic substances, and to clear waste products. The archetypal vascular …
The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway
PM Sullivan, X Zhou, AM Robins, DH Paushter… - Acta neuropathologica …, 2016 - Springer
Hexanucleotide repeat expansion in the C9orf72 gene is a leading cause of frontotemporal
lobar degeneration (FTLD) with amyotrophic lateral sclerosis (ALS). Reduced expression of …
lobar degeneration (FTLD) with amyotrophic lateral sclerosis (ALS). Reduced expression of …
Genetics of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a devastating, uniformly lethal degenerative disorder
of motor neurons that overlaps clinically with frontotemporal dementia (FTD). Investigations …
of motor neurons that overlaps clinically with frontotemporal dementia (FTD). Investigations …